Brief: InMed Provides Business Update And Milestones For 2023

InMed Pharmaceuticals

10/01/2023 12:33

Jan 10 (Reuters) - InMed Pharmaceuticals Inc  INM.O :
    * INMED PROVIDES BUSINESS UPDATE AND MILESTONES FOR 2023
    * INMED PHARMACEUTICALS INC - COMPLETE PHASE 2 CLINICAL
TRIAL
ENROLLMENT IN EPIDERMOLYSIS BULLOSA IN 1Q 2023
    * INMED PHARMACEUTICALS INC - PROGRESS PRECLINICAL RESEARCH
IN
GLAUCOMA IN PREPARATION FOR HUMAN TRIALS
    * INMED PHARMACEUTICALS- ADVANCE RESEARCH USING RARE
CANNABINOIDS
IN TREATING NEURODEGENERATIVE DISEASES SUCH AS ALZHEIMER'S,
HUNTINGTON'S & PARKINSON'S
    * INMED PHARMACEUTICALS INC - OUTLINES KEY ACCOMPLISHMENTS
FROM
2022 AND PROVIDES BUSINESS UPDATE AND CATALYSTS FOR 2023

Source text for Eikon:  ID:nGNX3z3GpP 
Further company coverage:  INM.O 
 ((reuters.briefs@thomsonreuters.com;))